| FTO modifies the m6A level of MALAT and promotes bladder cancer progression L Tao, X Mu, H Chen, D Jin, R Zhang, Y Zhao, J Fan, M Cao, Z Zhou Clinical and translational medicine 11 (2), e310, 2021 | 104 | 2021 |
| Curcumin inhibits cell proliferation and motility via suppression of TROP2 in bladder cancer cells L Zhang, G Yang, R Zhang, L Dong, H Chen, J Bo, W Xue, Y Huang International journal of oncology 53 (2), 515-526, 2018 | 59 | 2018 |
| Comprehensive genomic profiling of neuroendocrine bladder cancer pinpoints molecular origin and potential therapeutics P Shen, Y Jing, R Zhang, MC Cai, P Ma, H Chen, G Zhuang Oncogene, 1, 2018 | 48 | 2018 |
| Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study J Hu, J Chen, Z Ou, H Chen, Z Liu, M Chen, R Zhang, A Yu, R Cao, ... Cell Reports Medicine 3 (11), 2022 | 45 | 2022 |
| Somatic FGFR3 mutations distinguish a subgroup of muscle-invasive bladder cancers with response to neoadjuvant chemotherapy Z Yang, R Zhang, Y Ge, X Qin, X Kang, Y Wang, X Zhang, C Song, ... EBioMedicine 35, 198-203, 2018 | 41 | 2018 |
| A genomic-clinicopathologic nomogram for the preoperative prediction of lymph node metastasis in bladder cancer SX Wu, J Huang, ZW Liu, HG Chen, P Guo, QQ Cai, JJ Zheng, HD Qin, ... EBioMedicine 31, 54-65, 2018 | 28 | 2018 |
| Urinary molecular pathology for patients with newly diagnosed urothelial bladder cancer R Zhang, J Zang, F Xie, Y Zhang, Y Wang, Y Jing, Y Zhang, Z Chen, ... The Journal of urology 206 (4), 873-884, 2021 | 26 | 2021 |
| Diffusion kurtosis imaging to assess correlations with clinicopathologic factors for bladder cancer: a comparison between the multi-b value method and the tensor … F Wang, HG Chen, RY Zhang, D Jin, SS Xu, GY Wu, JR Xu European radiology 29, 4447-4455, 2019 | 21 | 2019 |
| Immunotherapy in the treatment of urothelial bladder cancer: insights from single-cell analysis J Zang, K Ye, Y Fei, R Zhang, H Chen, G Zhuang Frontiers in Oncology 11, 696716, 2021 | 17 | 2021 |
| Co-expression of stem cell and epithelial mesenchymal transition markers in circulating tumor cells of bladder cancer patients R Zhang, J Xia, Y Wang, M Cao, D Jin, W Xue, Y Huang, H Chen OncoTargets and therapy, 10739-10748, 2020 | 16 | 2020 |
| BCMab1-Ra, a novel immunotoxin that BCMab1 antibody coupled to Ricin A chain, can eliminate bladder tumor C Li, R Yan, Z Yang, H Wang, R Zhang, H Chen, J Wang Oncotarget 8 (28), 46704, 2017 | 15 | 2017 |
| Comparing renal function preservation after laparoscopic radio frequency ablation assisted tumor enucleation and laparoscopic partial nephrectomy for clinical T1a renal tumor … L Zhu, G Wu, J Huang, J Wang, R Zhang, W Kong, W Xue, Y Huang, ... Journal of cancer research and clinical oncology 143, 905-912, 2017 | 10 | 2017 |
| Peritumoral artery scoring system: A novel scoring system to predict renal function outcome after laparoscopic partial nephrectomy R Zhang, G Wu, J Huang, O Shi, W Kong, Y Chen, J Xu, W Xue, J Zhang, ... Scientific Reports 7 (1), 2853, 2017 | 7 | 2017 |
| The pathological and clinical response of the luminal and basal subtypes of muscle-invasive bladder cancer to neoadjuvant cisplatin-based chemotherapy and radical cystectomy … R Zhang, H Chen, J Xia, O Shi, M Cao, D Jin, C Li, G Zhuang, Q Liu, ... European Urology Supplements 3 (16), e303-e304, 2017 | 7 | 2017 |
| Aberrantly glycosylated integrin α3β1 is a unique urinary biomarker for the diagnosis of bladder cancer D Jin, R Zhang, H Chen, C Li Aging (Albany NY) 12 (11), 10844, 2020 | 6 | 2020 |
| The value of blood oxygen level dependent (BOLD) imaging in evaluating post-operative renal function outcomes after laparoscopic partial nephrectomy G Wu, R Zhang, H Mao, Y Chen, G Liu, J Zhang European Radiology 28, 5035-5043, 2018 | 5 | 2018 |
| Synergistic induction of tertiary lymphoid structures by chemoimmunotherapy in bladder cancer L Zhang, R Zhang, D Jin, T Zhang, A Shahatiaili, J Zang, L Wang, Y Pu, ... British Journal of Cancer, 1-11, 2024 | 2 | 2024 |
| Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer R Zhang, J Zang, D Jin, F Xie, A Shahatiaili, G Wu, L Zhang, L Wang, ... Clinical Cancer Research 29 (20), 4040-4046, 2023 | 2 | 2023 |
| Integrated longitudinal circulating tumor DNA profiling predicts immunotherapy response of metastatic urothelial carcinoma in the POLARIS‐03 trial J Zang, R Zhang, D Jin, F Xie, A Shahatiaili, G Wu, Y Zhang, Z Zhao, P Du, ... The Journal of Pathology 261 (2), 198-209, 2023 | 2 | 2023 |
| Prevalence and clonality of synchronous primary carcinomas in the bladder and prostate Y Jing, R Zhang, P Ma, MC Cai, G Zhuang, H Chen The Journal of Pathology 244 (1), 5-10, 2018 | 2 | 2018 |
